Compare IXHL & MGYR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
| Metric | IXHL | MGYR |
|---|---|---|
| Founded | 2001 | 1922 |
| Country | Australia | United States |
| Employees | N/A | N/A |
| Industry | | Savings Institutions |
| Sector | | Finance |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 134.7M | 115.3M |
| IPO Year | N/A | 2006 |
| Metric | IXHL | MGYR |
|---|---|---|
| Price | $0.36 | $17.63 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 7.5M | 4.1K |
| Earning Date | 02-13-2026 | 01-22-2026 |
| Dividend Yield | N/A | ★ 2.05% |
| EPS Growth | N/A | ★ 27.11 |
| EPS | N/A | ★ 1.56 |
| Revenue | $12,000.00 | ★ $35,207,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $11.30 |
| Revenue Growth | N/A | ★ 11.78 |
| 52 Week Low | $0.08 | $13.52 |
| 52 Week High | $2.25 | $19.04 |
| Indicator | IXHL | MGYR |
|---|---|---|
| Relative Strength Index (RSI) | 40.72 | 54.40 |
| Support Level | $0.34 | $17.50 |
| Resistance Level | $0.42 | $17.94 |
| Average True Range (ATR) | 0.02 | 0.09 |
| MACD | -0.00 | -0.02 |
| Stochastic Oscillator | 21.16 | 49.30 |
Incannex Healthcare Inc is a clinical stage pharmaceutical company developing medical cannabis products for the treatment of Obstructive Sleep Apnea (OSA), Traumatic Brain Injury (TBI)/Concussion, Rheumatoid Arthritis, Inflammatory Bowel Disease, and Inflammatory Lung Conditions. The company has an Australian license to import, export, and distribute medicinal cannabis products and has launched a line of cannabinoid products. The Company operates and manages its business as one reportable and operating segment, which is the Research and Development of the use of psychedelic medicine and therapies.
Magyar Bancorp Inc is an independent, community financial services provider offering traditional banking services to individual, business, and government customers. The Company attracts retail deposits through its main office in New Brunswick, New Jersey, and branch offices in Middlesex and Somerset Counties, and invests those funds mainly in commercial and residential real estate loans, commercial business loans, SBA loans, home equity loans and lines of credit, construction and land loans, and investment securities. Revenues are derived mainly from interest on loans and securities and from fees and service charges, with lending relationships focused on small to mid-sized businesses and individual consumers in central and northern New Jersey.